484 related articles for article (PubMed ID: 20100555)
1. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Int J Pharm; 2010 Apr; 389(1-2):254-61. PubMed ID: 20100555
[TBL] [Abstract][Full Text] [Related]
2. Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter.
Vighi E; Montanari M; Ruozi B; Tosi G; Magli A; Leo E
Eur J Pharm Biopharm; 2010 Nov; 76(3):384-93. PubMed ID: 20691262
[TBL] [Abstract][Full Text] [Related]
3. Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector.
Vighi E; Montanari M; Hanuskova M; Iannuccelli V; Coppi G; Leo E
Int J Pharm; 2013 Jan; 440(2):161-9. PubMed ID: 22982257
[TBL] [Abstract][Full Text] [Related]
4. The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier.
Vighi E; Montanari M; Ruozi B; Iannuccelli V; Leo E
Drug Deliv; 2012 Jan; 19(1):1-10. PubMed ID: 22070724
[TBL] [Abstract][Full Text] [Related]
5. Ternary nanoparticles of anionic lipid nanoparticles/protamine/DNA for gene delivery.
Yuan H; Zhang W; Du YZ; Hu FQ
Int J Pharm; 2010 Jun; 392(1-2):224-31. PubMed ID: 20230883
[TBL] [Abstract][Full Text] [Related]
6. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Eur J Pharm Biopharm; 2007 Sep; 67(2):320-8. PubMed ID: 17368876
[TBL] [Abstract][Full Text] [Related]
7. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.
Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK
Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199
[TBL] [Abstract][Full Text] [Related]
8. Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery.
Yu W; Liu C; Ye J; Zou W; Zhang N; Xu W
Nanotechnology; 2009 May; 20(21):215102. PubMed ID: 19423923
[TBL] [Abstract][Full Text] [Related]
9. Employment of cationic solid-lipid nanoparticles as RNA carriers.
Montana G; Bondì ML; Carrotta R; Picone P; Craparo EF; San Biagio PL; Giammona G; Di Carlo M
Bioconjug Chem; 2007; 18(2):302-8. PubMed ID: 17253655
[TBL] [Abstract][Full Text] [Related]
10. Cationic star polymers consisting of alpha-cyclodextrin core and oligoethylenimine arms as nonviral gene delivery vectors.
Yang C; Li H; Goh SH; Li J
Biomaterials; 2007 Jul; 28(21):3245-54. PubMed ID: 17466370
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands.
Pedersen N; Hansen S; Heydenreich AV; Kristensen HG; Poulsen HS
Eur J Pharm Biopharm; 2006 Feb; 62(2):155-62. PubMed ID: 16290122
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study.
Park YJ; Liang JF; Ko KS; Kim SW; Yang VC
J Gene Med; 2003 Aug; 5(8):700-11. PubMed ID: 12898639
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy.
del Pozo-Rodríguez A; Solinís MA; Gascón AR; Pedraz JL
Eur J Pharm Biopharm; 2009 Feb; 71(2):181-9. PubMed ID: 18940256
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical and transfection properties of cationic Hydroxyethylcellulose/DNA nanoparticles.
Fayazpour F; Lucas B; Alvarez-Lorenzo C; Sanders NN; Demeester J; De Smedt SC
Biomacromolecules; 2006 Oct; 7(10):2856-62. PubMed ID: 17025362
[TBL] [Abstract][Full Text] [Related]
15. High mobility group box 1 protein enhances polyethylenimine mediated gene delivery in vitro.
Shen Y; Peng H; Deng J; Wen Y; Luo X; Pan S; Wu C; Feng M
Int J Pharm; 2009 Jun; 375(1-2):140-7. PubMed ID: 19442462
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA:poly(L-lysine) complexes.
Aral C; Akbuga J
J Pharm Pharm Sci; 2003; 6(3):321-6. PubMed ID: 14738712
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
[TBL] [Abstract][Full Text] [Related]
18. [Chitosan nanoparticles as gene vector: effect of particle size on transfection efficiency].
Yang XR; Zong L; Yuan XY
Yao Xue Xue Bao; 2007 Jul; 42(7):774-9. PubMed ID: 17882964
[TBL] [Abstract][Full Text] [Related]
19. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors.
Singh R; Pantarotto D; McCarthy D; Chaloin O; Hoebeke J; Partidos CD; Briand JP; Prato M; Bianco A; Kostarelos K
J Am Chem Soc; 2005 Mar; 127(12):4388-96. PubMed ID: 15783221
[TBL] [Abstract][Full Text] [Related]
20. Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway.
Delgado D; del Pozo-Rodríguez A; Solinís MÁ; Rodríguez-Gascón A
Eur J Pharm Biopharm; 2011 Nov; 79(3):495-502. PubMed ID: 21726641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
